Über hormonale Sterilisierung weiblicher Tiere durch subcutane Transplantation von Ovarien trächtiger Weibchen

Haberlandt, L.

doi:10.1007/bf01884149

Cited by 21 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…He reported this in the Münchner Medizinische Wochenschrift [2], then a part of Pflügers Archiv (for [3], and caused much scientific interest. His observations were surprisingly simple, and thus were sometimes referred to as "the egg of Columbus".…”

Section: Summary Ludwig Haberlandtmentioning

confidence: 96%

“…After he committed suicide, on 22 July 1932, scientific discussion about hormonal contraception ceased until 1970 when scientists began referring to his earlier medical and scientific work. Between 1909 and 1931 Ludwig Haberlandt published a total of 134 scientific papers and presentations, only 14 of which were publications dealing with "hormonal contraception of the female organism" [2][3][4][5]. His primary scientific interest was in heart physiology.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Ludwig Haberlandt – Ein Pionier der hormonalen Kontrazeption

Haberlandt

2009

Wien Klin Wochenschr

View full text Add to dashboard Cite

Ludwig Haberlandt (1 February 1885 - 22 July 1932), pioneer in hormonal contraception, was born in Graz, where he graduated from the university in 1909 in medicine summa cum laude and began his career as a physiologist. The idea of temporary hormonal contraception in the female body entered his mind in February 1919, when he was already Professor of Physiology in Innsbruck. He pursued his project ambitiously and by 1921 demonstrated temporary hormonal contraception in a female animal by transplanting ovaries from a second, pregnant, animal. From 1923, after further successful scientific work in this field, he began highlighting the importance of clinical trials in presentations. From then, he was criticized by his colleagues, who accused him of hindering unborn life. His idea was contradictory to the moral, ethic, religious and political agendas of that time in Europe. In 1927 official reports escalated, his family was ostracized by the local population, and Ludwig Haberlandt refused any further interviews. Against all opposition, in 1930 he began clinical trials after successful production of a hormonal preparation, Infecundin, by the G. Richter Company in Budapest, Hungary. Although at the peak of his scientific career, he was unable to pursue other scientific agendas because of the disputed contraception project. After he committed suicide, on 22 July 1932, scientific discussion about hormonal contraception ceased until 1970 when scientists began referring to his earlier medical and scientific work.

show abstract

Section: Summary Ludwig Haberlandtmentioning

confidence: 96%

mentioning

confidence: 99%

Ludwig Haberlandt – Ein Pionier der hormonalen Kontrazeption

Haberlandt

2009

Wien Klin Wochenschr

View full text Add to dashboard Cite

show abstract

“…Alles schien nun optimal, doch der frühe Tod der Mutter warf 1911 einen dunklen Schatten auf die Berliner Zeit, die er retrospektiv als "erlebnisschweres und arbeitsreiches Berliner Jahr" beschrieb [1]. Es zog ihn weg aus der lauten Großstadt und dem großen Institut, an eine kleine reichsdeutsche Universität, um "… seine Höchstleistungen unter möglichst geringen äußeren Hemmungen ausführen zu können …" [1] [9,10] (▶ Abb. 3).…”

Section: Kurzer Lebenslaufunclassified

Ludwig Haberlandt (1885 – 1932) und die Anfänge der endokrinen Verhütung

Ebert¹,

Haberlandt²,

David³

2017

Geburtshilfe Frauenheilkd

View full text Add to dashboard Cite

“…As regards the inhibition of oestrus, Haberlandt (256) found that the graft of a third ovary into a normal rabbit caused prolonged inhibition of ovulation. Subsequent examination of the graft showed that no corpora lutea were present, but that the interstitial tissue, as is usual in such grafts, was highly developed.…”

Section: {E) Maintenance Of Pregnancymentioning

confidence: 99%